J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e76-e79. doi: 10.1016/j.japh.2020.06.004. Epub 2020 Jun 15.
The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services.
2020 年美国冠状病毒病大流行，在全国范围内对远程医疗服务的快速实施产生了巨大需求，而这些服务在远程医疗服务范围有限的地区是不可能实现的。如果没有医疗保险和医疗补助服务中心对这些服务报销方式的改变，这一切都不可能实现。药剂师有多种报销选择，但这取决于当地的规定或在现场改变实践的能力。尽管药剂师提供高质量的直接患者护理，但即使国家扩大远程医疗模式，他们也被排除在提供这种护理的补偿之外。这一概述表明，尽管医疗服务提供者的远程医疗服务补偿有所改变，但药剂师仍然无法为其直接的患者护理服务寻求适当的补偿。
